Iridex Q3 EPS $(0.11) Beats $(0.12) Estimate, Sales $12.85M Miss $13.48M Estimate
Author: Benzinga Newsdesk | November 14, 2023 06:21pm
Iridex (NASDAQ:
IRIX) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is unchanged from the same period last year. The company reported quarterly sales of $12.85 million which missed the analyst consensus estimate of $13.48 million by 4.67 percent. This is a 12.20 percent decrease over sales of $14.63 million the same period last year.
Posted In: IRIX